About GCSA

GCSA’s “right first time” and “quality built in” ethos facilitates process excellence and seamless collaboration between sponsors, CROs and clinical trial sites.

Evidenced  Assessment Process<br />

Benefits for Patients, Sites and Sponsors

Better for Patients

  • Truly patient-focused
  • Better experience for all participants
  • Reassures patients they’re in safe hands
  • Improved patient outcomes
  • Improved access and choices for patients
  • Increased opportunities for diverse range of patients to get involved in research

Better for Clients

  • Easily identifiable certification mark
  • Simple for clients to categorise suppliers at the organizational level, based on independent assessment
  • Reassures clients they’re in safe hands – builds Sponsor confidence
  • Faster, better quality clinical trials
  • Improved patient retention
  • Drives cost efficiencies
  • Supports reduced monitoring and oversight
  • Improved communication between client and site

Better for Business

  • Increases attraction of commercial clinical trials – more competitive, globally
  • Enhances reputation as a clinical research partner of choice
  • Distinctive certification mark for use on all communications
  • Increased income
  • Facilitates streamlining of Regulatory, Ethics and site approvals and contracts (NHS)
  • Costs savings through efficiencies and effectiveness
  • Improved marketing and promotional opportunities
  • Recognition as a leader in clinical research best practices

Better for Workforce

  • Improved talent attraction and retention
  • Enhances staff engagement
  • Shared learning
    and continuous development and improvement
  • Best practice advice & support
  • Improved competence and confidence

Better for Quality

  • Better site performance
  • Highlights areas for corrective action and continuous improvement
  • Reduces errors & risk
  • Integral part of the Quality management system
  • Fewer protocol deviations
  • Better data quality
  • Supports inspection and audit readiness
  • Validates the overall quality landscape

GCSA Demonstrates Commitment to Quality

Commitment to the GCSA journey demonstrates dedication to quality, the desire for ensuring high-quality patient experience, and the aspiration to be a clinical trial site of choice.

Distinctive certification marks are awarded on a modular basis, evidencing that participating sites have met rigorous, independently-assessed quality standards.

Our

Ambition

GCSA’s ambition is to play a significant role in creating a clinical research ecosystem, shaping the future of healthcare and improving people’s lives around the world.

Expediting Best Practice Sharing

GCSA facilitates networking to expedite best practice sharing and innovation through it’s Global Advisory Board, Taskforces, education and development activities and Think Tanks.

Our forward thinking sites

Founding Members of the

GCSA Global Advisory Board

 

Elizabeth Edwards
Biomat USA
Samin Saeed
Novartis / ABPI Representative
John Mellelieu
Pfizer
Teresa Allen
HRA (Health Research Authority)
Janet Messer
HRA (Health Research Authority)
Sandra Johnson
MMV (Medicines for Malaria Venture) 
Maria Palmer
NHS R&D Forum
Simon Lewis
NHS – London North West University Healthcare
Emer MacSweeney
Re:Cognition Health
Agnieszka Gackowska
Parexel
Karen McIntyre
Syneos Health

A global quality standard for clinical trial sites developed with a Global Advisory Board of stakeholders from across the clinical research industry.

+44 (0)1628 784906 (UK HQ)
+1 (855) 209 2335 (US Toll Free)